Tuesday, November, 12, 2019 01:27:56

Category: Pharmaceuticals

AbCellera to sign multi-target partnership deal with Novartis

AbCellera Biologics Inc., the antibody therapeutics developer based in Vancouver, has reportedly entered into a multi-year, multi-target partnership agreement with Novartis International AG, the Swiss multinational pharmaceutical company. Reportedly, the agreement entails the identification of antibodies for about ten therapeutic targets in the pipeline of …

GrapheneCA plans graphene production for cosmetics & pharma sectors

Nano Graphene Inc. (also known as GrapheneCA), a US-based supplier of graphene-based materials, has reportedly announced its plans to make graphene readily available for use in the cosmetics and pharmaceutical industries. Reportedly, GrapheneCA’s latest move helps in paving the path for the introduction & licensing …

CherryCircle Software raises $2.3m to advance its software innovations

 The investment round saw the participation of Hudson Park Capital, PLH Business Ventures, ATX Seed Ventures, and several other industry veterans.  CherryCircles’ software lets the pharma companies to capture development knowledge over time and handle risk across numerous dimensions with data. The US-based CherryCircle Software, …

Dr Reddy’s declares launch of Propofol Injectable Emulsion in the U.S.

Renowned pharmaceuticals company Pharma major Dr Reddy’s Laboratories Ltd., has reportedly brought the Propofol Injectable Emulsion to the U.S. shores. Propofol, a therapeutic generic equivalent version of Diprivan (propofol) Injectable Emulsion, has been given the green signal by the U.S. Food and Drug Administration and …